Share Share on Facebook Share on Twitter Pinterest Email Cleo Diagnostics (COV:AU) has announced CLEO Further Expands Ovarian Cancer Trial with Siles Health Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Q1 2025 Management’s Discussion and Analysis May 14, 2025 Q1 2025 Interim Financial Statements May 14, 2025 3 Best-performing Canadian Rare Earth Stocks in 2025 May 13, 2025